Navigation Links
Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
Date:11/19/2012

trategic Alliance Focused Primarily on Metabolic Diseases.  In August 2012, Regulus entered into a strategic alliance with AstraZeneca AB ("AZ") to discover, develop, and commercialize microRNA therapeutics for three exclusive targets focused on cardiovascular and metabolic diseases and oncology.  AZ made an upfront payment of $3.0 million and purchased $25.0 million of Regulus' common stock in a private placement that closed concurrently with the IPO. In addition, Regulus is eligible to receive preclinical, clinical and commercialization milestone payments of up to $509.0 million, as well as royalties. 
  • Established Research Collaboration to Explore microRNA Biomarkers for Multiple Sclerosis.  In August 2012, Regulus formed a collaboration with Biogen Idec Inc. ("Biogen Idec") to explore microRNA biomarkers for multiple sclerosis.  Regulus received an upfront payment of $750,000 and is eligible to receive milestone payments of up to $1.3 million.  Regulus also received $5.0 million from the sale of a convertible note to Biogen Idec which converted into shares of Regulus' common stock at the closing of the IPO. 
  • Re-Aligned Board of Directors.  In November 2012, Douglas E. Williams, Ph.D., Executive Vice President of Research and Development at Biogen Idec, joined Regulus' Board of Directors.  Concurrently, Stanley T. Crooke, M.D., Ph.D., Chairman of the Board and CEO of Isis Pharmaceuticals, Inc., and Barry E. Greene, President and Chief Operating Officer of Alnylam Pharmaceuticals, Inc., stepped down from the Board and their respective Board committees. 
  • Third Quarter 2012 Financial Results & HighlightsAs of September 30, 2012, Regulus had cash, cash equivalents and short-term investments of $30.9 million compared to $38.1 million at December 31, 2011.  The decrease in cash, cash equivalents and short-term investments was the result of approximately $17.7 m
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    2. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    3. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
    4. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
    5. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
    6. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
    7. Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
    8. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
    9. ULURU Inc. Reports Third Quarter 2012 Financial Results
    10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
    11. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
    (Date:7/29/2014)...  Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... closing of the NASDAQ Global Market on Tuesday, August ... by Michael Martino , president and CEO, and ... the same day at 5:00 pm EDT (2:00 pm ...
    (Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
    Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
    ... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
    ... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
    Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
    (Date:7/29/2014)... 2014 For survivors of severe combat injuries threatening ... flaps have a good record of safety and effectiveness ... issue of Plastic and Reconstructive Surgery ... Society of Plastic Surgeons (ASPS). , Experience with ... and Afghanistan shows good success rates, with no increase ...
    (Date:7/29/2014)... By Randy Dotinga ... (HealthDay News) -- When most children take on a ... less of this neuro-boosting activity in kids with autism, ... with more severe symptoms of autism displayed even less ... ,"This reduced flexibility often causes difficulty when children ...
    (Date:7/29/2014)... (HealthDay News) -- Although the bite of a brown ... if left alone, an expert notes. It,s still ... reaction to a brown recluse spider bite, warned Dr. ... particularly since these potentially dangerous bites are on the ... to do nothing. The [bite] has classic characteristics, but ...
    (Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... the website of Time Magazine titled “From Kim’s Butt ... Kim Kardashian’s butt is the celebrity feature ... and their features include Beyoncé’s butt, Jennifer Lawrence’s ... lips. This information is based on data collected by ...
    (Date:7/29/2014)... (July 29, 2014) Using quality improvement measures in ... England Cardiovascular Disease Study Group, researchers have found a ... procedure with contrast dye. , Currently, 7-15 percent of ... contrast-dye end up with kidney injury, which can result ... to temporary or permanent dialysis, says a study published ...
    Breaking Medicine News(10 mins):Health News:Good outcomes with multiple limb salvage after severe combat injuries, reports Plastic and Reconstructive Surgery 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Reducing kidney injury using a quality improvement method 2
    ... Disease are more likely to display abnormal social behaviour ... are pathological gamblers, according to research in the January ... A number of studies have already associated pathological ... impulse control disorder associated mainly with dopamine replacement therapy. ...
    ... which have no tangible existence, arise out of physical ... Institute of Science provided evidence, for the first time, ... experience of seeing. In research recently published in ... research student Lior Fisch of the Weizmann Institute,s Neurobiology ...
    ... simple and inexpensive eye test could aid detection and diagnosis ... stage than is currently possible, according to new research by ... & Stephen Moss and published today in Cell Death ... and therefore brain cell death, to be directly measured in ...
    ... ... ... SonRidge, LLC, a catering and chef supplies company located in Western Massachusetts, found themselves in ... industry. What they discovered was an innovative resolution that not only solved an issue for ...
    ... , , EUGENE, Ore. , ... group gaining national recognition for its unprecedented work, has released ... Preventing HIV/AIDS for Women with Intellectual Disabilities. , With AIDS ... 25 - 44 in the United States , this ...
    ... ... DRE Velocity EKG, a portable PC-based EKG/ECG system that provides powerful data and analysis functions. ... (Vocus) January 14, 2010 ... —offers the DRE Velocity EKG , a 12-channel PC-based EKG system that provides impressive ...
    Cached Medicine News:Health News:Parkinson's patients who are pathological gamblers also display abnormal social behavior 2Health News:To see or not to see 2Health News:Seeing a diagnosis: How an eye test could aid Alzheimer's detection 2Health News:Insulated Transport Containers Go Green 2Health News:The Tech-Aid Institute Releases HIV/AIDS Prevention Software for Women with Intellectual Disabilities 2Health News:Cost-effective PC-based EKG Now Available from DRE 2Health News:Cost-effective PC-based EKG Now Available from DRE 3
    ... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
    Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
    Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
    ... Cauteries provide a broad selection ... in a wide variety of ... cautery is packaged sterile, complete ... lock switch in the "off ...
    Medicine Products: